Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$15.81 - $18.96 $28,869 - $34,620
-1,826 Closed
0 $0
Q4 2023

Jan 19, 2024

BUY
$8.12 - $10.63 $14,827 - $19,410
1,826 New
1,826 $19,000
Q1 2023

Apr 18, 2023

BUY
$8.36 - $11.37 $15,265 - $20,761
1,826 New
1,826 $16,000
Q3 2022

Oct 13, 2022

SELL
$6.86 - $11.95 $12,526 - $21,820
-1,826 Closed
0 $0
Q2 2022

Jul 15, 2022

BUY
$7.38 - $10.4 $9,165 - $12,916
1,242 Added 212.67%
1,826 $14,000
Q1 2022

Apr 26, 2022

BUY
$7.33 - $9.39 $4,280 - $5,483
584 New
584 $5,000
Q4 2021

Jan 13, 2022

SELL
$7.9 - $10.19 $8,010 - $10,332
-1,014 Closed
0 $0
Q1 2021

Sep 20, 2021

BUY
$10.34 - $12.81 $10,484 - $12,989
1,014 New
1,014 $12,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Activest Wealth Management Portfolio

Follow Activest Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Activest Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Activest Wealth Management with notifications on news.